Paper8980409
Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.
Kerr DJ and 12 others. Br J Cancer, 1996. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution. Papers, record 8980409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8980409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimetabolites, Antineoplastic | Major topic |
| Drug Delivery Systems | Major topic |
| Fluorouracil | Major topic |
| Peritoneal Neoplasms | Major topic |
| Adult | |
| Aged | |
| Drug Carriers | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Infusions, Parenteral | |
| Male | |
| Middle Aged | |
| Peritoneal Dialysis |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05913674 | Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) | Background |
Source ClinicalTrials.gov
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7438049 | Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy. | Cancer Res | 1980 | https://conductscience.org/library/papers/7438049 | PubMed |
| 2 | 7214359 | Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. | Cancer Res | 1981 | https://conductscience.org/library/papers/7214359 | PubMed |
| 3 | 7239541 | Penetration of substances into tumor tissue--a methodological study on cellular spheroids. | In Vitro | 1981 | https://conductscience.org/library/papers/7239541 | PubMed |
| 4 | 2926468 | A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2926468 | PubMed |
| 5 | 7917936 | Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma. | Br J Cancer | 1994 | https://conductscience.org/library/papers/7917936 | PubMed |
| 6 | 2688796 | Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. | Br J Surg | 1989 | https://conductscience.org/library/papers/2688796 | PubMed |
| 7 | 2043717 | The analysis of 5-fluorouracil in human plasma by gas chromatography-negative ion chemical ionization mass spectrometry (GC-NICIMS) with stable isotope dilution. | J Pharm Biomed Anal | 1991 | https://conductscience.org/library/papers/2043717 | PubMed |
| 8 | 1551172 | Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1551172 | PubMed |
| 9 | 8137338 | Pharmacokinetic principles of locoregional chemotherapy. | Cancer Surv | 1993 | https://conductscience.org/library/papers/8137338 | PubMed |
| 10 | 2293556 | Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. | Cancer Res | 1990 | https://conductscience.org/library/papers/2293556 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22415741 | Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis. | Int J Clin Oncol | 2013 | https://conductscience.org/library/papers/22415741 | PubMed |
| 18407591 | Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats. | World J Gastroenterol | 2008 | https://conductscience.org/library/papers/18407591 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8980409
GET https://conductscience.org/api/papers/v1/8980409/authors